These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Altering airway surface liquid volume: inhalation therapy with amiloride and hyperosmotic agents. Hirsh AJ Adv Drug Deliv Rev; 2002 Dec; 54(11):1445-62. PubMed ID: 12458154 [TBL] [Abstract][Full Text] [Related]
7. ENaC-mediated effects assessed by MRI in a rat model of hypertonic saline-induced lung hydration. Blé FX; Cannet C; Collingwood S; Danahay H; Beckmann N Br J Pharmacol; 2010 Jun; 160(4):1008-15. PubMed ID: 20590595 [TBL] [Abstract][Full Text] [Related]
8. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Robinson M; Regnis JA; Bailey DL; King M; Bautovich GJ; Bye PT Am J Respir Crit Care Med; 1996 May; 153(5):1503-9. PubMed ID: 8630593 [TBL] [Abstract][Full Text] [Related]
10. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Robinson M; Hemming AL; Regnis JA; Wong AG; Bailey DL; Bautovich GJ; King M; Bye PT Thorax; 1997 Oct; 52(10):900-3. PubMed ID: 9404379 [TBL] [Abstract][Full Text] [Related]
11. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study. Robinson M; Daviskas E; Eberl S; Baker J; Chan HK; Anderson SD; Bye PT Eur Respir J; 1999 Sep; 14(3):678-85. PubMed ID: 10543292 [TBL] [Abstract][Full Text] [Related]
12. Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis. Laube BL; Sharpless G; Carson KA; Kelly A; Mogayzel PJ BMC Pulm Med; 2011 Sep; 11():45. PubMed ID: 21896198 [TBL] [Abstract][Full Text] [Related]
13. Nebulised hypertonic saline for cystic fibrosis. Wark PA; McDonald V; Jones AP Cochrane Database Syst Rev; 2005 Jul; (3):CD001506. PubMed ID: 16034863 [TBL] [Abstract][Full Text] [Related]
14. Timing of hypertonic saline inhalation for cystic fibrosis. Elkins M; Dentice R Cochrane Database Syst Rev; 2020 Feb; 2(2):CD008816. PubMed ID: 32107770 [TBL] [Abstract][Full Text] [Related]
16. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy. App EM; King M; Helfesrieder R; Köhler D; Matthys H Am Rev Respir Dis; 1990 Mar; 141(3):605-12. PubMed ID: 2310093 [TBL] [Abstract][Full Text] [Related]
17. Duration of action of hypertonic saline on mucociliary clearance in the normal lung. Bennett WD; Wu J; Fuller F; Balcazar JR; Zeman KL; Duckworth H; Donn KH; O'Riordan TG; Boucher RC; Donaldson SH J Appl Physiol (1985); 2015 Jun; 118(12):1483-90. PubMed ID: 25911685 [TBL] [Abstract][Full Text] [Related]
18. Effect of amiloride and saline on nasal mucociliary clearance and potential difference in cystic fibrosis and normal subjects. Middleton PG; Geddes DM; Alton EW Thorax; 1993 Aug; 48(8):812-6. PubMed ID: 8211871 [TBL] [Abstract][Full Text] [Related]
19. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. Knowles MR; Church NL; Waltner WE; Yankaskas JR; Gilligan P; King M; Edwards LJ; Helms RW; Boucher RC N Engl J Med; 1990 Apr; 322(17):1189-94. PubMed ID: 2157983 [TBL] [Abstract][Full Text] [Related]
20. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]